BackgroundCheck.run
Search For

Chad D Hopkins, 457409 Mason Heights Ln, San Diego, CA 92126

Known as:
Chad E Hopkins Chad S Hopkins
Related to:
Megan Hopkins Danny Hopkins 74

Chad Hopkins Phones & Addresses

7409 Mason Heights Ln, San Diego, CA 92126   

West Palm Beach, FL   

Michigan City, MS   

Jupiter, FL   

Pittsburgh, PA   

Lawrence, KS   

6174 Seven Springs Blvd, Greenacres, FL 33463    561-9693364   

Work

Position: Protective Service Occupations

Education

Degree: Graduate or professional degree
Get Report
Control this profile

Mentions for Chad D Hopkins

Career records & work history

License Records

Chad Everett Hopkins

Licenses:
License #: 7029018 - Active
Category: EMS Licensing
Issued Date: Jun 17, 2016
Expiration Date: Jun 30, 2018
Type: EMT-Paramedic

Chad Hopkins resumes & CV records

Resumes

Chad Hopkins Photo 41

Associate Director, Preclinical Research And Development At Kalyra Pharmaceuticals

Location:
San Diego, CA
Industry:
Pharmaceuticals
Work:
Kalyra Pharmaceuticals
Associate Director, Preclinical Research and Development at Kalyra Pharmaceuticals Kalyra Pharmaceuticals Jan 2018 - Jan 2018
Senior Principal Scientist Kalyra Pharmaceuticals Dec 2013 - Aug 2015
Senior Scientist Opko Health, Inc. May 2011 - Mar 2013
Senior Staff Scientist University of Pittsburgh Mar 2007 - Mar 2011
Postdoctoral Associate The University of Kansas Jan 2002 - Feb 2007
Research Associate
Education:
The University of Kansas 2001 - 2007
Doctorates, Doctor of Philosophy, Organic Chemistry Mississippi State University 1999 - 2001
Bachelors, Bachelor of Science, Chemistry
Skills:
Organic Synthesis, Hplc, Medicinal Chemistry, Small Molecules, Organometallic Chemistry, Peptide Synthesis, Solid Phase Synthesis, Total Synthesis, Organic Chemistry, Microarray Analysis, Microarray, Electronic Lab Notebooks, Chemical Safety, Project Coordination, Team Leadership, Elisa
Chad Hopkins Photo 42

Owner

Location:
West Palm Beach, FL
Industry:
Consumer Services
Work:
Hopkins Air Conditioning
Owner
Skills:
Heating, Indoor Air Quality, Customer Service, Sales, Team Building, Contract Negotiation, Account Management, Air Conditioning, Hvac, Strategic Planning, Management, Sales Management, Hvac Controls, New Business Development
Chad Hopkins Photo 43

Chad Hopkins

Chad Hopkins Photo 44

Career Specialist

Work:

Career Specialist
Chad Hopkins Photo 45

Chad Hopkins

Chad Hopkins Photo 46

Chad Hopkins

Chad Hopkins Photo 47

Chad Hopkins

Chad Hopkins Photo 48

Chad Hopkins

Publications & IP owners

Us Patents

Estrogen Receptor Modulators

US Patent:
2021033, Oct 28, 2021
Filed:
Jul 6, 2021
Appl. No.:
17/305369
Inventors:
- San Diego CA, US
Deborah Helen Slee - Encinitas CA, US
Sayee Gajanan Hegde - San Diego CA, US
Chad Daniel Hopkins - San Diego CA, US
Kevin Duane Bunker - Escondido CA, US
Joseph Robert Pinchman - San Diego CA, US
Rakesh Kumar Sit - San Diego CA, US
International Classification:
A61K 31/438
A61K 31/437
A61P 5/30
A61P 35/00
C07B 59/00
C07C 69/738
C07C 69/757
C07D 209/10
C07D 471/04
C07C 69/732
Abstract:
Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.

Substituted 1,2-Dihydro-3H-Pyrazolo[3,4-D]Pyrimidin-3-Ones

US Patent:
2021013, May 13, 2021
Filed:
Feb 26, 2019
Appl. No.:
16/971254
Inventors:
- San Diego CA, US
Kevin Duane Bunker - Escondido CA, US
Brant Clayton Boren - San Diego CA, US
Sayee Gajanan Hegde - San Diego CA, US
Hui Liu - San Diego CA, US
Aditya Krishnan Unni - San Diego CA, US
Sunny Abraham - San Diego CA, US
Chad Daniel Hopkins - San Diego CA, US
Sunil Paliwal - Monroe Township NJ, US
International Classification:
C07D 487/04
C07D 491/048
Abstract:
Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as breast cancer.

Acrylic Acid Analogs

US Patent:
2021009, Apr 1, 2021
Filed:
Jul 26, 2018
Appl. No.:
16/634366
Inventors:
- San Diego CA, US
Deborah Helen Slee - Encinitas CA, US
Kevin Duane Bunker - Escondido CA, US
Sayee Gajanan Hegde - San Diego CA, US
Chad Daniel Hopkins - San Diego CA, US
International Classification:
C07C 59/56
C07C 255/57
A61P 35/00
Abstract:
Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as breast cancer.

Spirocyclic Compounds

US Patent:
2020026, Aug 27, 2020
Filed:
Jan 6, 2020
Appl. No.:
16/734857
Inventors:
- San Diego CA, US
Mehmet Kahraman - San Diego CA, US
Deborah Helen Slee - Encinitas CA, US
Kevin Duane Bunker - Escondido CA, US
Chad Daniel Hopkins - San Diego CA, US
Joseph Robert Pinchman - San Diego CA, US
Sunny Abraham - San Diego CA, US
Rakesh Kumar Sit - San Diego CA, US
Daniel Lee Severance - San Diego CA, US
International Classification:
A61K 31/4162
C07D 487/10
C07D 471/10
A61P 35/00
A61K 31/416
Abstract:
Disclosed herein are spirocyclic compounds, together with pharmaceutical compositions and methods of ameliorating and/or treating a cancer described herein with one or more of the compounds described herein.

Estrogen Receptor Modulators

US Patent:
2020026, Aug 20, 2020
Filed:
May 5, 2020
Appl. No.:
16/866900
Inventors:
- San Diego CA, US
Deborah Helen Slee - Encinitas CA, US
Sayee Gajanan Hegde - San Diego CA, US
Chad Daniel Hopkins - San Diego CA, US
Kevin Duane Bunker - Escondido CA, US
Joseph Robert Pinchman - San Diego CA, US
Rakesh Kumar Sit - San Diego CA, US
International Classification:
A61K 31/438
C07C 69/757
C07B 59/00
C07D 471/04
C07C 69/732
C07C 69/738
A61K 31/437
A61P 35/00
A61P 5/30
Abstract:
Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.

Estrogen Receptor Modulators

US Patent:
2020026, Aug 20, 2020
Filed:
May 5, 2020
Appl. No.:
16/866995
Inventors:
- San Diego CA, US
Deborah Helen Slee - Encinitas CA, US
Sayee Gajanan Hegde - San Diego CA, US
Chad Daniel Hopkins - San Diego CA, US
Kevin Duane Bunker - Escondido CA, US
Joseph Robert Pinchman - San Diego CA, US
Rakesh Kumar Sit - San Diego CA, US
International Classification:
A61K 31/438
C07C 69/757
C07B 59/00
C07D 471/04
C07C 69/732
C07C 69/738
A61K 31/437
A61P 35/00
A61P 5/30
Abstract:
Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.

Estrogen Receptor Modulators

US Patent:
2020026, Aug 20, 2020
Filed:
May 5, 2020
Appl. No.:
16/867017
Inventors:
- San Diego CA, US
Deborah Helen Slee - Encinitas CA, US
Sayee Gajanan Hegde - San Diego CA, US
Chad Daniel Hopkins - San Diego CA, US
Kevin Duane Bunker - Escondido CA, US
Joseph Robert Pinchman - San Diego CA, US
Rakesh Kumar Sit - San Diego CA, US
International Classification:
A61K 31/438
C07C 69/757
C07B 59/00
C07D 471/04
C07C 69/732
C07C 69/738
A61K 31/437
A61P 35/00
A61P 5/30
Abstract:
Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.

Egfr Inhibitor Compounds

US Patent:
2020018, Jun 11, 2020
Filed:
Dec 4, 2019
Appl. No.:
16/703544
Inventors:
- San Diego CA, US
Peter Qinhua Huang - San Diego CA, US
Sunny Abraham - San Diego CA, US
Joseph Robert Pinchman - San Diego CA, US
Chad Daniel Hopkins - San Diego CA, US
Deborah Helen Slee - Encinitas CA, US
International Classification:
C07D 403/04
C07D 471/04
C07D 403/14
A61K 31/506
A61P 35/00
Abstract:
Disclosed herein are nitrogen-containing bicyclic compounds, together with pharmaceutical compositions and methods of ameliorating and/or treating a cancer described herein with one or more of the compounds described herein.

Possible Relatives

Cynthia A Hopkins  David L Hopkins  Dean Hopkins  Deann L Hopkins  Deanna Hopkins  Deb L Hopkins  Dallas W Hopkins  Chad K Johnson  Chad B Stamps  Chad E Stander 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.